<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03117296</url>
  </required_header>
  <id_info>
    <org_study_id>10437</org_study_id>
    <nct_id>NCT03117296</nct_id>
  </id_info>
  <brief_title>Physical Therapy and Occupational Therapy After Transcatheter Aortic Valve Replacement</brief_title>
  <acronym>PTOTtAVR</acronym>
  <official_title>Physical Therapy and Occupational Therapy After Transcatheter Aortic Valve Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henry Ford Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Henry Ford Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Henry Ford Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Implementation of Physical Therapy (PT) and Occupational Therapy (OT) pathway (initiation of&#xD;
      services on Post procedure day #1 and continued daily with focus on education and activity&#xD;
      progression) for all patients undergoing a transcatheter aortic value repair procedure began&#xD;
      on December 2, 2014. Retrospective data was collected from The Society of Thoracic&#xD;
      Surgeons/American College of Cardiology Transcatheter Aortic Valve Replacement Procedures&#xD;
      (STS/ACC TVT, trademark) Registry - National database for Transcatherter Aortic Valve&#xD;
      Replacement Procedures and included subjects from March 2012 through July 31, 2015. Patients&#xD;
      included: s/p tAVR via transfemoral catheter approach, with or without minor intra or post&#xD;
      procedure events (GI bleeds, minor access bleeds, afib, etc); Exclusions: Major events&#xD;
      including stroke, pacemaker placement, other cardiovascular (CV) repair or surgery required,&#xD;
      etc). Future data analysis will extend subjects to December 31, 2015 and annually.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: Frequency of transcatheter and other structural heart procedures increased&#xD;
      dramatically from 2012 to 2014 and is trending even higher for 2015. Procedures increased&#xD;
      from 15 in 2012 to 50 cases in 2013 (233% increase) and to 70 cases in 2014 (40% increase&#xD;
      from 2013 to 2014.) -- PT and OT identified a gap in consults and need for specific education&#xD;
      targeted for a new surgery population (tAVR) without sternotomy. Often consults were placed&#xD;
      on day of discharge to rehab facility or not at all. -- Structural Heart division of CV&#xD;
      institute identified increased length of stay (LOS) and decreased activity of their patients&#xD;
      in the hospital. -- No literature on this subject found via Henry Ford Hospital Sladen&#xD;
      Library PubMed literature review&#xD;
&#xD;
      Aim: • Create a standardized pathway for new transcatheter aortic valve replacement patients&#xD;
      in the Structural Heart Division (SHD)&#xD;
&#xD;
        -  Improve patient outcomes including increasing the percentage of patients returning to&#xD;
           home rather than a rehab facility destination at discharge&#xD;
&#xD;
        -  Decrease length of stay&#xD;
&#xD;
      Implementation:&#xD;
&#xD;
        -  Plan: PT and OT identified a gap in consults and need for specific education targeted at&#xD;
           a new surgeries population (tAVR); Structural Heart division of CV institute identified&#xD;
           an increase LOS and decreased activity of their patients in the hospital. In October&#xD;
           2014 planning began to introduce a SHD tAVR pathway that would include post procedure&#xD;
           day number 0 nursing requirements and training, post procedure day number 1-3 PT and OT&#xD;
           assessment and interventions.&#xD;
&#xD;
        -  Do: Implemented pathway in November 2014.&#xD;
&#xD;
        -  Check: Order set revision; Patient handouts ; Cardiac Rehab; Weekend criteria; staff&#xD;
           training&#xD;
&#xD;
        -  Act: February 2015, order sets in place, patient handouts finalized and full pathway&#xD;
           finalized for post op tAVR patients.&#xD;
&#xD;
        -  Continued checks identified additional SHD procedures and team determined that Mitral&#xD;
           Clips and LARIATs were not criteria for tAVR pathway but would receive routine PT and OT&#xD;
           consults.&#xD;
&#xD;
      Intervention: • Added PT and OT to Structural Heart Order Set.&#xD;
&#xD;
        -  PT and OT assessments completed on post procedure day number day 1.&#xD;
&#xD;
        -  PT and OT follow up treatments post procedure day number 2, 3 and beyond as appropriate.&#xD;
&#xD;
        -  Patient education handouts individualized for patient population&#xD;
&#xD;
        -  Pre-op education handouts individualized for patient population&#xD;
&#xD;
      Outcome measures: Hospital Length of stay, discharge disposition. Data Analysis: Chi-square&#xD;
      tests are used to compare proportions between groups, while Wilcoxon two-sample tests are&#xD;
      used to compare distributions of continuous variables between groups. This nonparametric test&#xD;
      was chosen due to non-Gaussian distribution of the continuous outcomes within groups.&#xD;
      Statistical significance was set at p&lt;0.05. All analyses were performed using SAS 9.4 (SAS&#xD;
      Institute Inc, Cary, North Carolina, USA).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date type="Actual">December 3, 2014</start_date>
  <completion_date type="Anticipated">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">July 31, 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>30 Days</target_duration>
  <primary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>From date of procedure until date of hospital discharge, assessed up to 50 days.</time_frame>
    <description>Hospital Length of Stay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Discharge disposition</measure>
    <time_frame>From date of discharge, single entry, up to one entry, assessed up to 50 days.</time_frame>
    <description>Discharge destination: 1=Home, 2=Nursing home, 3=Extended care/rehab, 4=Other</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Transcatheter Aortic Valve Implantation</condition>
  <arm_group>
    <arm_group_label>Post procedure routine PT and or OT</arm_group_label>
    <description>Routine PT and or OT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post Procedure PT and OT pathway</arm_group_label>
    <description>Post procedure day zero nursing mobilization; post procedure day one PT and OT assessment and intervention, daily PT and OT intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Post procedure daily PT and OT</intervention_name>
    <description>PT evaluation and treatment on post procedure day zero: Nurses mobility patient using egress testing one time</description>
    <arm_group_label>Post Procedure PT and OT pathway</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PT post procedure</intervention_name>
    <description>post procedure day one: PT and OT assessment, education and intervention.</description>
    <arm_group_label>Post Procedure PT and OT pathway</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>OT post procedure</intervention_name>
    <description>PT and OT Daily until goals met or patient discharge.</description>
    <arm_group_label>Post Procedure PT and OT pathway</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Routine PT or OT</intervention_name>
    <description>Routine PT or OT consulted by physician when identified discharge disposition of home</description>
    <arm_group_label>Post procedure routine PT and or OT</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive population sample of patients at Henry Ford Hospital, Detroit, Michigan&#xD;
        undergoing transcatheter aortic valve replacement via femoral access in cath lab from March&#xD;
        2012 to present.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  admission to henry ford hospital after March 1, 2012&#xD;
&#xD;
          -  status post transcatheter aortic valve replacement via transfemoral catheter approach,&#xD;
             with or without minor intra or post procedure events (GI bleeds, minor access bleeds,&#xD;
             afib, etc)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Occurrence of major events including stroke, pacemaker placement, other CV repair or&#xD;
             surgery required, etc)&#xD;
&#xD;
          -  procedure via appropriate other than femoral access (transapical, transcaval)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adele Myszenski, MPT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henry Ford Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra SA, Mavromatis K, Leshnower BG, Guyton RA, Kanitkar M, Keegan P, Simone A, Stewart JP, Ghasemzadeh N, Block P, Thourani VH. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014 Aug;7(8):898-904. doi: 10.1016/j.jcin.2014.04.005. Epub 2014 Jul 30.</citation>
    <PMID>25086843</PMID>
  </reference>
  <reference>
    <citation>Marcantuono R, Gutsche J, Burke-Julien M, Anwaruddin S, Augoustides JG, Jones D, Mangino-Blanchard L, Hoke N, Houseman S, Li R, Patel P, Stetson R, Walsh E, Szeto WY, Herrmann HC. Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR). Catheter Cardiovasc Interv. 2015 Mar;85(4):648-54. doi: 10.1002/ccd.25749. Epub 2014 Nov 29.</citation>
    <PMID>25413312</PMID>
  </reference>
  <reference>
    <citation>Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP; SURTAVI Investigators. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017 Apr 6;376(14):1321-1331. doi: 10.1056/NEJMoa1700456. Epub 2017 Mar 17.</citation>
    <PMID>28304219</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>April 7, 2017</study_first_submitted>
  <study_first_submitted_qc>April 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2017</study_first_posted>
  <last_update_submitted>April 14, 2017</last_update_submitted>
  <last_update_submitted_qc>April 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henry Ford Health System</investigator_affiliation>
    <investigator_full_name>Adele Myszenski</investigator_full_name>
    <investigator_title>Supervisor, Physical Therapist</investigator_title>
  </responsible_party>
  <keyword>physical therapy</keyword>
  <keyword>occupational therapy</keyword>
  <keyword>tAVR</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Shared internally on a secure intranet via REDcap or Excel database with identifying information removed.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

